L. Castillo

Effect of age and race on quality of life in young breast cancer survivors.

G. Hortobagyi, L. Schover, M. Munsell, 2014, Clinical breast cancer.

Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial

C. Cleeland, T. Mendoza, F. Meric-Bernstam, 2022, Scientific Reports.

Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors

K. Hess, I. Wistuba, Gopal Singh, 2020, Journal for ImmunoTherapy of Cancer.

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory

K. Hess, C. Cleeland, T. Mendoza, 2020, Journal for ImmunoTherapy of Cancer.